In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agents
Affiliations
Affiliations
- Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait. john@hsc.edu.kw
01 January 2013
Abstract
Background & objectives: There is an increasing frequency of resistance of Campylobacter jejuni to antimicrobial agents making treatment difficult. In this study, the in vitro susceptibility of C. jejuni isolates collected over an eight year period was tested against tigecycline, a glycylcycline, the previously tested antimicrobial agents in Kuwait, ciprofloxacin, erythromycin and tetracycline, and other antimicrobial agents not previously tested in Kuwait, amoxicillin-clavulanic acid, gentamicin, imipenem and meropenem.
Methods: A total of 97 C. jejuni isolates from diarrhoeal stools of Kuwaiti patients during 2002-2010 were studied for susceptibility to the above antimicrobial agents by E test.
Results: Erythromycin resistance increased from 5.0 per cent in 2002-2003 to 13.8 per cent in 2007-2010. The figures for ciprofloxacin resistance for the same periods were 53 and 65.5 per cent, respectively. Tetracycline resistance increased from 40.0 per cent in 2003-2006 to 62.1 per cent in 2007-2010 (P=0.05). However, all isolates were uniformly susceptible to tigecycline and other antimicrobial agents.
Interpretation & conclusions: There was a progressive increase in the prevalence of resistance to ciprofloxacin, erythromycin and tetracycline. As all isolates were uniformly susceptible to tigecycline, this antimicrobial agent can be considered as a potential candidate for treatment in clinical studies.
Similar articles
Lehtopolku M, Nakari UM, Kotilainen P, Huovinen P, Siitonen A, Hakanen AJ.Antimicrob Agents Chemother. 2010 Mar;54(3):1232-6. doi: 10.1128/AAC.00898-09. Epub 2009 Dec 28.PMID: 20038624 Free PMC article.
Gaudreau C, Gilbert H.Antimicrob Agents Chemother. 2003 Jun;47(6):2027-9. doi: 10.1128/AAC.47.6.2027-2029.2003.PMID: 12760892 Free PMC article.
Szczepanska B, Andrzejewska M, Spica D, Klawe JJ.BMC Microbiol. 2017 Apr 4;17(1):80. doi: 10.1186/s12866-017-0991-9.PMID: 28376713 Free PMC article.
Tetracycline resistance is frequent among Campylobacter jejuni isolates from Kuwait.
Albert MJ, Udo E, Jose BT, Haridas S, Rotimi VO.Microb Drug Resist. 2009 Jun;15(2):115-20. doi: 10.1089/mdr.2009.0892.PMID: 19432521
Žemličková H, Jakubů V, Marejková M, Urbášková P.Epidemiol Mikrobiol Imunol. 2014 Sep;63(3):184-90.PMID: 25412481 Czech.
Cited by
Sharifi S, Bakhshi B, Najar-Peerayeh S.Ann Clin Microbiol Antimicrob. 2021 May 20;20(1):36. doi: 10.1186/s12941-021-00439-6.PMID: 34016127 Free PMC article.
Bakhshi B, Naseri A, Alebouyeh M.Iran Biomed J. 2016;20(2):91-6. doi: 10.7508/ibj.2016.02.004. Epub 2015 Nov 25.PMID: 26783018 Free PMC article.
KMEL References
References
-
- Albert MJ, Neil L, Pazhoor A, Haridas S, Rotimi V, Khan I. Ciprofloxacin resistance and its molecular mechanism in Campylobacter spp. isolated in Kuwait. Microb Drug Resist. 2005;11:266–70. - PubMed
-
- Moore JE, Barton MD, Blair IS, Corcoran D, Dooley JSG, Fanning S, et al. The epidemiology of antibiotic resistance in Campylobacter. Microb Infect. 2006;8:1955–66. - PubMed
-
- Rodriguez-Avial I, Rodriguez-Avial C, Lopez O, Culebras E, Picazo JJ. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline - and ciprofloxacin-resistant Campylobacter clinical isolates. Int J Antimicrob Agents. 2006;27:303–6. - PubMed
-
- Wardak S, Szych J. Tigecycline susceptibilities of tetracycline-resistant Campylobacter jejuni strains isolated in Poland. Med Dosw Mikrobiol. 2010;62:345–50. - PubMed
-
- Albert MJ, Udo E, Jose BT, Haridas S, Rotimi VO. Tetracycline resistance is frequent among Campylobacter jejuni isolates from Kuwait. Microb Drug Resist. 2009;15:115–20. - PubMed